[News Brief] Australia Approves OncoSil™ Device for Pancreatic Cancer
Australia’s Therapeutic Goods Administration (TGA) has approved the OncoSil™ medical device for use in patients with locally advanced pancreatic cancer.…
Pharmaceuticals & Supplements
[News Brief] Lotus Pharmaceutical Acquires UTI Product Rights in South Korea
Lotus Pharmaceutical, a Taiwan-based company, has entered into an agreement with OM Pharma to acquire the assets of a specialty…
[News Brief] China Formalises Drug Trial Data Protection Measures
China’s National Medical Products Administration (NMPA) has issued new implementation measures formalising protection for eligible undisclosed drug trial data submitted…
[News Brief] Ribo and Insilico Medicine Form AI-siRNA Collaboration
Suzhou Ribo Life Science Co., Ltd. and Insilico Medicine have entered into a strategic collaboration to integrate artificial intelligence platforms…
[News Brief] Agilent and NATi Partner on Oligonucleotide Research in Singapore
Agilent Technologies and Singapore’s Nucleic Acid Therapeutics Initiative (NATi) have entered a two-year research collaboration to advance analytical workflows for…
[News Brief] Nuance Pharma Secures IND Approval for Actair® Trial
Nuance Pharma has received Investigational New Drug (IND) clearance from China’s National Medical Products Administration to begin a Phase III…
[News Brief] HKSAR Government Promotes Health Innovation in Switzerland
The Secretary for Health of Hong Kong SAR, Professor Lo Chung-mau, met multinational pharmaceutical and healthcare companies in Zurich, Switzerland…
[News Brief] AstraZeneca Enters Licensing Agreement with CSPC Pharmaceuticals
AstraZeneca has entered into a strategic collaboration with CSPC Pharmaceutical Group to obtain ex-China rights to a weight management portfolio…
[News Brief] GSK Enters Strategic Collaboration with SBP Group
GSK plc has entered into an exclusive strategic collaboration with Sino Biopharmaceutical (SBP Group), through its subsidiary Chia Tai Tianqing…
[News Brief] Amplexd Therapeutics Starts Phase 2 HPV Trial
Amplexd Therapeutics has received authorisation from the Hong Kong Department of Health to begin a Phase 2 trial of an…